An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Investigational Drug Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to message these profiles directly for supplier links, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and assertions of rapid UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Medical Experts Express Concerns
However, doctors and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in users injecting substances of uncertain source.
Some professionals stated the popularity for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or prison.
Platform Response and Material Removal
According to the social media company, the service has taken down violative content and prohibited associated keywords and search suggestions. The company stated it was dedicated to keeping the platform secure and allocating resources in enhancing enforcement strategies.
Online Trading Operations
Investigations also discovered communities with up to 9,000 members marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of users, populated with images of weight loss, glowing testimonials and detailed guides for preparing or administering at home.
After minutes of joining one group, a vendor posted WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.
Product Details and Costs
Within these communities, posts show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for the messaging service said it actively moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her team has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a Lilly investigational product not yet approved … may expose patients to possibly serious health risks”.
